What is NTHI's Value Score?

NeOnc Technologies Holdings, Inc. - Common Stock (NTHI) has a StockPik Value Score of 30 out of 100 — a low score, indicating weak value characteristics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is NTHI's Piotroski F-Score?

NeOnc Technologies Holdings, Inc. - Common Stock (NTHI) has a Piotroski F-Score of 1 out of 9 — a weak score indicating financial deterioration across multiple criteria. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

What is NTHI's Piotroski F-Score?

NTHI's Piotroski F-Score is 1 out of 9, indicating weak financial health and possible deterioration. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is NTHI (NeOnc Technologies Holdings, Inc. - Common Stock) undervalued?

NTHI scores 30/100 on StockPik's Value Score.

What sector is NeOnc Technologies Holdings, Inc. - Common Stock (NTHI) in?

NeOnc Technologies Holdings, Inc. - Common Stock (NTHI) is in the Healthcare sector, specifically in the Pharmaceutical Preparations industry. Compare it against other Healthcare stocks by Value Score, P/E ratio, and Piotroski F-Score on StockPik.

Back to Screener

NeOnc Technologies Holdings, Inc. - Common Stock (NTHI)

NASDAQ Micro Cap

Healthcare › Pharmaceutical Preparations

$5.50

Market Cap: $139M

Data as of Sep 30, 2025 (TTM)

Price History

Feb 9, 2026 — May 12, 2026

Investment Snapshot

Piotroski F-Score 1/9 — signs of financial weakness
Negative net margin (-136,240.5%) — currently unprofitable
Revenue declining 52% annually

NeOnc Technologies Holdings, Inc. - Common Stock (NTHI) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $139 million . Key value metrics: Piotroski F-Score 1 out of 9 .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

—

P/B Ratio

—

EPS

$-2.15

Div. Yield

—

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Financial Statements

Metric	FY22	FY23	FY24
Revenue	$X.XB	$X.XB	$X.XB
Gross Profit	$X.XB	$X.XB	$X.XB
Operating Income	$X.XB	$X.XB	$X.XB
Net Income	$X.XB	$X.XB	$X.XB
EBITDA	$X.XB	$X.XB	$X.XB
Total Assets	$X.XB	$X.XB	$X.XB
Total Liabilities	$X.XB	$X.XB	$X.XB

Unlock 5 Years of Financials — Start Free Trial

Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

NeOnc Technologies Holdings, Inc. - Common Stock — Fundamental Analysis Summary

StockPik's composite Value Score for NTHI is 30/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

NTHI shows revenue declining at 52% year-over-year, with earnings declining at 422%.

Top Value Stocks in Healthcare

Symbol	Name	Price	P/E	Score
EMBC	Embecta Corp. - Common Stock	$3.90	2.1	100
HCM	HUTCHMED (China) Limited - American Depositary Shares	$13.31	5.1	100
GMAB	Genmab A/S - American Depositary Shares	$27.06	1.8	100
CGEN	Compugen Ltd. - Ordinary Shares	$2.71	7.3	100
INVA	Innoviva, Inc. - Common Stock	$22.89	5.8	100

Browse all Healthcare value stocks →

How is the Value Score calculated?

Read our full methodology →

What is the Piotroski F-Score?

The 9-point financial health score explained, with worked examples →

NTGR — NETGEAR, Inc. - Common Stock

Northern Technologies International Corporation - Common Stock — NTIC